Services
A.
Fragment-Based Drug Discovery (FBDD)
- High-throughput fragment library screening
- Hit identification and validation
- Fragment binding kinetics
B.
Hit-to-Lead & Lead Optimization
- Multi-dose response studies
- Structure-activity relationship (SAR) support
- Binding kinetics characterization (ka, kd, KD)
- Residence time analysis
C.
Antibody Characterization
- Antigen-antibody affinity determination
- Off-rate ranking from crude samples
- Cross-reactivity and specificity profiling
- Epitope binning
- FcγR and FcRn binding analysis
- Bispecific antibody characterization
D.
Target Validation & Mode of Action
- Protein-protein interactions
- Competition assays
- Co-binding studies (allosteric vs. active site)
- Stoichiometry determination

